Literature DB >> 23568031

Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis.

Abdel Nasser Hosein1, Sarah Song, Amy E McCart Reed, Janani Jayanthan, Lynne E Reid, Jamie R Kutasovic, Margaret C Cummings, Nic Waddell, Sunil R Lakhani, Georgia Chenevix-Trench, Peter T Simpson.   

Abstract

Pathology archives contain vast resources of clinical material in the form of formalin-fixed paraffin-embedded (FFPE) tissue samples. Owing to the methods of tissue fixation and storage, the integrity of DNA and RNA available from FFPE tissue is compromized, which means obtaining informative data regarding epigenetic, genomic, and expression alterations can be challenging. Here, we have investigated the utility of repairing damaged DNA derived from FFPE tumors prior to single-nucleotide polymorphism (SNP) arrays for whole-genome DNA copy number analysis. DNA was extracted from FFPE samples spanning five decades, involving tumor material obtained from surgical specimens and postmortems. Various aspects of the protocol were assessed, including the method of DNA extraction, the role of Quality Control quantitative PCR (qPCR) in predicting sample success, and the effect of DNA restoration on assay performance, data quality, and the prediction of copy number aberrations (CNAs). DNA that had undergone the repair process yielded higher SNP call rates, reduced log R ratio variance, and improved calling of CNAs compared with matched FFPE DNA not subjected to repair. Reproducible mapping of genomic break points and detection of focal CNAs representing high-level gains and homozygous deletions (HD) were possible, even on autopsy material obtained in 1974. For example, DNA amplifications at the ERBB2 and EGFR gene loci and a HD mapping to 13q14.2 were validated using immunohistochemistry, in situ hybridization, and qPCR. The power of SNP arrays lies in the detection of allele-specific aberrations; however, this aspect of the analysis remains challenging, particularly in the distinction between loss of heterozygosity (LOH) and copy neutral LOH. In summary, attempting to repair DNA that is damaged during fixation and storage may be a useful pretreatment step for genomic studies of large archival FFPE cohorts with long-term follow-up or for understanding rare cancer types, where fresh frozen material is scarce.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568031     DOI: 10.1038/labinvest.2013.54

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

Review 1.  Endoscopic ultrasound guided fine needle aspiration and useful ancillary methods.

Authors:  Mario Tadic; Tajana Stoos-Veic; Rajko Kusec
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 2.  Tumour heterogeneity: principles and practical consequences.

Authors:  Giorgio Stanta; Stephan Wenzel Jahn; Serena Bonin; Gerald Hoefler
Journal:  Virchows Arch       Date:  2016-07-13       Impact factor: 4.064

3.  Successful restoration of archived ovine formalin fixed paraffin-embedded tissue DNA and single nucleotide polymorphism analysis.

Authors:  Amanda Kravitz; Ron Tyler; B Murali Manohar; B Samuel Masilamoni Ronald; Michael T Collins; Nammalwar Sriranganathan
Journal:  Vet Res Commun       Date:  2022-05-26       Impact factor: 2.459

4.  Applicability of next-generation sequencing to decalcified formalin-fixed and paraffin-embedded chronic myelomonocytic leukaemia samples.

Authors:  Veronica Bernard; Niklas Gebauer; Thomas Dinh; Judith Stegemann; Alfred C Feller; Hartmut Merz
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

5.  A novel molecular diagnostics platform for somatic and germline precision oncology.

Authors:  Rubén Cabanillas; Marta Diñeiro; David Castillo; Patricia C Pruneda; Cristina Penas; Guadalupe A Cifuentes; Álvaro de Vicente; Noelia S Durán; Rebeca Álvarez; Gonzalo R Ordóñez; Juan Cadiñanos
Journal:  Mol Genet Genomic Med       Date:  2017-04-23       Impact factor: 2.183

6.  Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.

Authors:  Agus Darwanto; Anne-Mette Hein; Sascha Strauss; Yi Kong; Andrew Sheridan; Dan Richards; Eric Lader; Monika Ngowe; Timothy Pelletier; Danielle Adams; Austin Ricker; Nishit Patel; Andreas Kühne; Simon Hughes; Dan Shiffman; Dirk Zimmermann; Kai Te Kaat; Thomas Rothmann
Journal:  BMC Cancer       Date:  2017-05-22       Impact factor: 4.430

7.  Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples.

Authors:  Luciano G Martelotto; Timour Baslan; Jude Kendall; Felipe C Geyer; Kathleen A Burke; Lee Spraggon; Salvatore Piscuoglio; Kalyani Chadalavada; Gouri Nanjangud; Charlotte K Y Ng; Pamela Moody; Sean D'Italia; Linda Rodgers; Hilary Cox; Arnaud da Cruz Paula; Asya Stepansky; Michail Schizas; Hannah Y Wen; Tari A King; Larry Norton; Britta Weigelt; James B Hicks; Jorge S Reis-Filho
Journal:  Nat Med       Date:  2017-02-06       Impact factor: 53.440

8.  Sources of erroneous sequences and artifact chimeric reads in next generation sequencing of genomic DNA from formalin-fixed paraffin-embedded samples.

Authors:  Simon Haile; Richard D Corbett; Steve Bilobram; Morgan H Bye; Heather Kirk; Pawan Pandoh; Eva Trinh; Tina MacLeod; Helen McDonald; Miruna Bala; Diane Miller; Karen Novik; Robin J Coope; Richard A Moore; Yongjun Zhao; Andrew J Mungall; Yussanne Ma; Rob A Holt; Steven J Jones; Marco A Marra
Journal:  Nucleic Acids Res       Date:  2019-01-25       Impact factor: 16.971

Review 9.  Clinical advances in molecular biomarkers for cancer diagnosis and therapy.

Authors:  Seema Sethi; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

10.  Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.

Authors:  Suet-Feung Chin; Angela Santonja; Marta Grzelak; Soomin Ahn; Stephen-John Sammut; Harry Clifford; Oscar M Rueda; Michelle Pugh; Mae A Goldgraben; Helen A Bardwell; Eun Yoon Cho; Elena Provenzano; Federico Rojo; Emilio Alba; Carlos Caldas
Journal:  Exp Mol Pathol       Date:  2018-03-31       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.